Amy Simon Beam Therapeutics Inc. (BEAM) insider trading activity

Amy Simon is Chief Medical Officer of Beam Therapeutics Inc.. Currently has a direct ownership of 70,060 shares of BEAM, which is worth approximately $1.67 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 16,530 shares (Common Stock) at a price of $30.54 per share, resulting in proceeds of $504,826. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.1K

7.01% 3M change

1.09% 12M change

Total Value Held $1.67 Million

Amy Simon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 02 2024	SELL Open market or private sale	$504,826 $30.54 p/Share	16,530 Reduced 19.09%	70,060 Common Stock
Apr 01 2024	SELL Open market or private sale	$229,954 $32.13 p/Share	7,157 Reduced 7.63%	86,590 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	-	27,500 Added 22.68%	93,747 Common Stock
Oct 30 2023	SELL Open market or private sale	$64,477 $18.7 p/Share	3,448 Reduced 5.0%	65,469 Common Stock
Jul 10 2023	SELL Open market or private sale	$11,917 $30.48 p/Share	391 Reduced 0.56%	68,917 Common Stock
Apr 04 2023	SELL Open market or private sale	$342,977 $29.43 p/Share	11,654 Reduced 14.39%	69,308 Common Stock
Apr 03 2023	SELL Open market or private sale	$134,727 $30.31 p/Share	4,445 Reduced 5.2%	80,962 Common Stock

Mar 31 2023	BUY Grant, award, or other acquisition	-	20,000 Added 19.02%	85,129 Common Stock

Amy Simon

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Value

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM

Account